204 related articles for article (PubMed ID: 37660645)
1. mRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy.
Zhang A; Ji Q; Sheng X; Wu H
Biomed Pharmacother; 2023 Oct; 166():115361. PubMed ID: 37660645
[TBL] [Abstract][Full Text] [Related]
2. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
3. Path towards mRNA delivery for cancer immunotherapy from bench to bedside.
Chen W; Zhu Y; He J; Sun X
Theranostics; 2024; 14(1):96-115. PubMed ID: 38164145
[TBL] [Abstract][Full Text] [Related]
4. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
Duan LJ; Wang Q; Zhang C; Yang DX; Zhang XY
Front Immunol; 2022; 13():923647. PubMed ID: 35711457
[TBL] [Abstract][Full Text] [Related]
5. mRNA vaccines for cancer immunotherapy.
Vishweshwaraiah YL; Dokholyan NV
Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
[TBL] [Abstract][Full Text] [Related]
6. mRNA Cancer Vaccines: Construction and Boosting Strategies.
Liu X; Huang P; Yang R; Deng H
ACS Nano; 2023 Oct; 17(20):19550-19580. PubMed ID: 37819640
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeutics.
Ritu ; Chandra P; Das A
Clin Exp Med; 2023 Dec; 23(8):4297-4322. PubMed ID: 37804358
[TBL] [Abstract][Full Text] [Related]
8. The use of RNA-based treatments in the field of cancer immunotherapy.
Chehelgerdi M; Chehelgerdi M
Mol Cancer; 2023 Jul; 22(1):106. PubMed ID: 37420174
[TBL] [Abstract][Full Text] [Related]
9. The future of cancer immunotherapy: DNA vaccines leading the way.
Pandya A; Shah Y; Kothari N; Postwala H; Shah A; Parekh P; Chorawala MR
Med Oncol; 2023 Jun; 40(7):200. PubMed ID: 37294501
[TBL] [Abstract][Full Text] [Related]
10. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Lorentzen CL; Haanen JB; Met Ö; Svane IM
Lancet Oncol; 2022 Oct; 23(10):e450-e458. PubMed ID: 36174631
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities.
Wang B; Pei J; Xu S; Liu J; Yu J
Front Immunol; 2023; 14():1246682. PubMed ID: 37744371
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
Malla R; Srilatha M; Farran B; Nagaraju GP
Mol Ther; 2024 Jan; 32(1):13-31. PubMed ID: 37919901
[TBL] [Abstract][Full Text] [Related]
13. Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine.
Parums DV
Med Sci Monit; 2021 May; 27():e933088. PubMed ID: 33994538
[TBL] [Abstract][Full Text] [Related]
14. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
15. Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development.
Cheng R; Xu Z; Luo M; Wang P; Cao H; Jin X; Zhou W; Xiao L; Jiang Q
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35279714
[TBL] [Abstract][Full Text] [Related]
16. mRNA Vaccine - A New Cancer Treatment Strategy.
Tan T; Deng ST; Wu BH; Yang Q; Wu MW; Wu H; Cao CH; Xu C
Curr Cancer Drug Targets; 2023; 23(9):669-681. PubMed ID: 36809966
[TBL] [Abstract][Full Text] [Related]
17. The clinical progress and challenges of mRNA vaccines.
Yu MZ; Wang NN; Zhu JQ; Lin YX
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1894. PubMed ID: 37096256
[TBL] [Abstract][Full Text] [Related]
18. Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors.
Zheng H; Li M; Wu L; Liu W; Liu Y; Gao J; Lu Z
Drug Deliv; 2023 Dec; 30(1):2161670. PubMed ID: 36587630
[TBL] [Abstract][Full Text] [Related]
19. mRNA vaccine in cancer therapy: Current advance and future outlook.
Li Y; Wang M; Peng X; Yang Y; Chen Q; Liu J; She Q; Tan J; Lou C; Liao Z; Li X
Clin Transl Med; 2023 Aug; 13(8):e1384. PubMed ID: 37612832
[TBL] [Abstract][Full Text] [Related]
20. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.
Bhargava A; Mishra D; Banerjee S; Mishra PK
J Drug Target; 2013 Feb; 21(2):126-36. PubMed ID: 23061479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
